[Use of the O6-Paris-LA-66 program in the treatment of patients with lymphoblastic leukemia under 20 years of age].
D000293:Adolescent; D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002648:Child; D003630:Daunorubicin / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D007945:Leukemia, Lymphoid / Q000188:drug therapy*; D008727:Methotrexate / Q000008:administration & dosage / Q000627:therapeutic use; D011239:Prednisolone / Q000008:administration & dosage / Q000627:therapeutic use; D013997:Time Factors; D014750:Vincristine / Q000008:administration & dosage / Q000627:therapeutic use
D014750:Vincristine; D011239:Prednisolone; D008727:Methotrexate; D003630:Daunorubicin
Opyt primeneniia programmy O6-Paris-LA-66 dlia lecheniia bol'nykh ostrym limfoblastnym leĭkozom v vozraste do 20 let.